IP Library Granted Patent US 8,376,188
Granted Patent B2
US 8,376,188 · App. 12/759,954 · Granted Feb 19, 2013

Device for the application of fibrin adhesive

Inventor: Jorge Maria Manzano Riera (Barcelona, ES)
Assignee: Grifols, S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,376,188
App. No.
12/759,954
Granted
Feb 19, 2013
Kind
B2
Abstract

A device for the application of two components of fibrin adhesive at a treatment site comprising a support for syringes comprising two parallel cylindrical housings to receive corresponding syringes and a plunger connecting member, characterised in that the said syringe support comprises a passage for insertion of the said plunger connecting member, the said passage being located in the space defined between the cylindrical housings of the said syringe support, the said plunger connector having a zone with a suitable geometry to slide within the said passage and in that the transverse cross-section of the said passage of the syringe support has a maximum opening at the ends and a minimum opening in the central part.

Claims (23)

1. A device for the application of two components of fibrin adhesive at a treatment site which comprises:

a support for syringes which comprises two parallel cylindrical housings extending along a longitudinal axis to receive corresponding syringes, and

a plunger connecting member,

wherein the support for syringes comprises a passage extending parallel to said two parallel cylindrical housings for insertion of the plunger connecting member, the passage being located in the space between the cylindrical housings of the syringe support, the plunger connecting member having a zone with a suitable geometry to slide into the passage and in that the passage defines a cross-section transverse to the longitudinal axis having a maximum size at a top and a bottom thereof and a minimum size at a center thereof.

2. A device according to claim 1 , wherein the transverse cross-section of the zone through which the plunger connecting member moves within the syringe support has the general shape of an I.

3. A device according to claim 1 , wherein the transverse cross-section of the zone through which the plunger connecting member moves within the syringe support has the general shape of an X.

4. A device according to claim 1 , wherein the syringe support comprises two housings of cylindrical shape suitable to receive standard syringes, the syringes being pressed into the housings.

5. A device according to claim 1 , wherein the syringe support has no components which will impede rotation of the bodies of the syringes once the syringes have been pressed into the syringe support.

6. A device according to claim 1 , wherein the plunger connecting member has no components which prevent rotation of the plungers once the plungers have been fitted in the plunger connecting member.

7. A device according to claim 1 , wherein the device also comprises an outlet body which is connected to the bodies of the syringes of the fibrin adhesive by screwing.

8. A device according to claim 1 , wherein the syringes have an upper part in the form of a flange and a lower part in the form of a thread.

9. A device according to claim 1 , wherein the syringes have the same diameter and volume.

10. A device according to claim 2 , wherein the syringe support comprises two housings of cylindrical shape suitable to receive standard syringes, the syringes being pressed into the housings.

11. A device according to claim 3 , wherein the syringe support comprises two housings of cylindrical shape suitable to receive standard syringes, the syringes being pressed into the housings.

12. A device according to claim 2 , wherein the syringe support has no components which will impede rotation of the bodies of the syringes once the syringes have been pressed into the syringe support.

13. A device according to claim 3 , wherein the syringe support has no components which will impede rotation of the bodies of the syringes once the syringes have been pressed into the syringe support.

14. A device according to claim 4 , wherein the syringe support has no components which will impede rotation of the bodies of the syringes once the syringes have been pressed into the syringe support.

15. A device according to claim 2 , wherein the plunger connecting member has no components which prevent rotation of the plungers once the plungers have been fitted in the plunger connecting member.

16. A device according to claim 3 , wherein the plunger connecting member has no components which prevent rotation of the plungers once the plungers have been fitted in the plunger connecting member.

17. A device according to claim 4 , wherein the plunger connecting member has no components which prevent rotation of the plungers once the the plungers have been fitted in the plunger connecting member.

18. A device according to claim 5 , wherein the plunger connecting member has no components which prevent rotation of the plungers once the plungers have been fitted in the plunger connecting member.

19. A device according to claim 2 , wherein the device further comprises an outlet body which is connected to the bodies of the syringes of the fibrin adhesive by screwing.

20. A device according to claim 3 , wherein the device further comprises an outlet body which is connected to the bodies of the syringes of the fibrin adhesive by screwing.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Feb 6, 2017
From: DEUTSCHE BANK AG NEW YORK BRANK
To: GRIFOLS THERAPEUTICS INC.; GRIFOLS SHARED SERVICES NORTH AMERICA INC.; GRIFOLS DIAGNOSTIC SOLUTIONS INC.
Reel/Frame 041638/0527 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 26390/0193 Recorded Jan 25, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: GRIFOLS, S.A.; GRIFOLS INC.; TALECRIS BIOTHERAPEUTICS, INC.
Reel/Frame 041494/0017 →
SECURITY AGREEMENT Recorded Feb 27, 2014
From: GRIFOLS INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS-CHIRON DIAGNOSTICS CORP.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032367/0001 →
SECURITY AGREEMENT Recorded Jun 3, 2011
From: GRIFOLS, S.A.; GRIFOLS INC.; TALECRIS BIOTHERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 026390/0193 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2010
From: MANZANO RIERA, JORGE MARIA
To: GRIFOLS, S.A.
Reel/Frame 024231/0106 →
Priority Claims (1)
ES 200930290 · Jun 9, 2009 · national
Continuity (1)
Related Publication 20100312274A1 · Dec 9, 2010